A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...
"It's going to be a while before we can get in there and build anything," said Michael Hricak, an adjunct professor of architecture at the Universityof SouthernCalifornia, referring to the ...
Some results have been hidden because they may be inaccessible to you